Only one has been shown in clinical trials to slow cognitive aging, by about two years. This is what the science says about ...
Cenrifki prevents MS disease progression and Itvisma delivers a healthy gene-to-cell nuclei, addressing the root cause of SMA.
Back pain can keep you from living life to the fullest, which is why prevention matters. If it strikes, you don’t have to ...
(“Encoded”), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, ...
Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare ...
Spinogenix, Inc.,  a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics designed to restore synapses to improve the lives of patients, will present this ...
Slimpic has emerged in 2026 as one of the most discussed natural weight management formulas in the prebiotic and probiotic ...
Days into the new year, a traveler with measles landed at Philadelphia International Airport, passed through bustling 30th Street Station, and boarded an Amtrak train to Baltimore. Thousands of ...
Egyptian patient, 22, receives Itvisma injection to treat spinal muscular atrophy ...
Spinal cord injuries typically result in permanent paralysis and loss of sensation, posing significant challenges for those ...